Oct 22, 2026 01:14PM

Oct 22, 2026 12:00PM

Oct 21, 2026 09:31PM

Oct 21, 2026 07:59PM

Oct 21, 2026 07:00PM

Oct 21, 2026 06:30PM

Oct 21, 2026 07:05AM FDA accepts Unicycive's OLC drug resubmission, sets March 2027 review date

Oct 21, 2026 07:05AM

Oct 20, 2026 04:17PM

Oct 1, 2026 07:05AM

Oct 1, 2026 07:05AM

Sep 29, 2026 03:21PM

Sep 29, 2026 07:05AM

Sep 29, 2026 07:05AM Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate

Aug 20, 2026 09:20AM

Aug 13, 2026 06:48AM

Aug 12, 2026 07:19AM

Jul 6, 2026 08:42AM

Jul 2, 2026 08:45AM

Jul 1, 2026 07:27AM

Jun 30, 2026 07:05AM FDA issues second complete response letter to Unicycive over OLC drug application

Jun 30, 2026 07:05AM

Jun 29, 2026 07:09AM

Jun 2, 2026 08:41AM

May 13, 2026 06:51AM

May 12, 2026 07:05AM

Apr 9, 2026 07:05AM

Apr 7, 2026 04:31PM Unicycive Therapeutics (UNCY) PT Lowered to $23 at Brookline Capital Markets

Apr 6, 2026 08:38AM

Apr 2, 2026 06:43AM

Mar 30, 2026 07:05AM

Mar 18, 2026 09:17AM

Mar 16, 2026 09:31AM

Mar 12, 2026 08:14AM

Mar 10, 2026 09:08AM Important Notice to Long-Term Shareholders of Boston Scientific Corporation (NYSE: BSX): Corcept Therapeutics, Inc. (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR): and Unicycive Therapeutics, Inc.

Mar 5, 2026 09:15AM

Feb 17, 2026 09:15AM

Feb 4, 2026 07:05AM

Jan 29, 2026 09:15AM

Jan 29, 2026 07:05AM

Jan 29, 2026 07:05AM

Dec 30, 2025 06:36AM Guggenheim Reiterates Buy Rating on Unicycive Therapeutics (UNCY)

Dec 29, 2025 07:05AM

Dec 29, 2025 07:05AM

Dec 3, 2025 09:13AM

Dec 2, 2025 12:39PM

Dec 1, 2025 01:41PM

Nov 25, 2025 07:05AM

Nov 14, 2025 09:26AM Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Five Below, Inc. (NASDAQ: FIVE); Maison Solutions Inc. (NASDAQ: MSS); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar

Nov 12, 2025 08:36AM

335,223 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All